Alcohol as a Target for Cancer Prevention and Control: Research Challenges

Event Type:
December 18, 2020
2:00 p.m. – 3:30 p.m. EST


Event Material

Event Series

Alcohol and Cancer

This webinar introduced NCI’s interest, investment and activities in alcohol and cancer research and a panel of experts discussed scientific evidence gaps related to the role of alcohol across the cancer continuum. Specifically, the webinar summarized what is known and what we need to know in cancer etiology, patient care and survivorship, policies, and communication relevant to alcohol as a target for cancer prevention and control. 

There was ample time for audience questions and comments as NCI seeks to further understand and support research on the epidemiology and biology of alcohol and cancer risk and prognosis, effects of alcohol use during and after cancer treatment, and individual and policy level interventions focused on reducing the burden of cancer caused by alcohol.


William P. Klein, Ph.D.
William P. Klein, Ph.D.

Associate Director,
Behavioral Research Program,
National Cancer Institute

Susan M. Gapstur, Ph.D., M.P.H.
Susan M. Gapstur, Ph.D., M.P.H.

Epidemiology Consultant,
Tiffin, Iowa

Kevin Shield, Ph.D.
Kevin Shield, Ph.D.

Head, Collaborating Centre in Addiction and Mental Health,
Pan American Health Organization,
Assistant Professor, Division of Epidemiology,
Dalla Lana School of Public Health,
University of Toronto

Noelle LoConte, M.D.
Noelle LoConte, M.D.

Associate Professor,
Division of Hematology, Medical Oncology and Palliative Care,
Department of Medicine,
University of Wisconsin, Madison

Timothy Naimi, M.D., M.P.H.
Timothy Naimi, M.D., M.P.H.

Canadian Institute for Substance Use Research

Courtney Scherr, Ph.D.
Courtney Scherr, Ph.D.

Assistant Professor,
Department of Communication Studies,
Northwestern University

Last Updated
March 16, 2022